标题
Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
作者
关键词
-
出版物
Cancers
Volume 9, Issue 12, Pages 57
出版商
MDPI AG
发表日期
2017-05-30
DOI
10.3390/cancers9060057
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme
- (2016) Zachary D. Nagel et al. CANCER RESEARCH
- Efficacy of PD-1 blockade in tumors with MMR deficiency
- (2016) Valerie Lee et al. Immunotherapy
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA repair mechanisms and their clinical impact in glioblastoma
- (2016) Hélène Erasimus et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Clonal evolution of glioblastoma under therapy
- (2016) Jiguang Wang et al. NATURE GENETICS
- NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells
- (2015) Zhiyun Yu et al. CANCER LETTERS
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
- (2015) Hoon Kim et al. GENOME RESEARCH
- The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment
- (2015) LAURA ANNOVAZZI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Repair mechanisms help glioblastoma resist treatment
- (2015) Ryan J. Atkins et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- The Microenvironment in Gliomas: Phenotypic Expressions
- (2015) Davide Schiffer et al. Cancers
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- (2015) Gloria Perazzoli et al. PLoS One
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment
- (2014) Daniela Chirio et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Solid Lipid Nanoparticles for Potential Doxorubicin Delivery in Glioblastoma Treatment: Preliminary In Vitro Studies
- (2014) Luigi Battaglia et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
- (2013) Eduardo C Filippi-Chiela et al. BMC CANCER
- Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide
- (2013) Marcus Eich et al. MOLECULAR CANCER THERAPEUTICS
- Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage
- (2013) Anna V. Knizhnik et al. PLoS One
- Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage
- (2013) Motokazu Ito et al. PLoS One
- Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double-Strand Break-Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein
- (2012) Alessandro Raso et al. BRAIN PATHOLOGY
- Chloroethylnitrosourea-induced cell death and genotoxicity: Cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ
- (2012) Teodora Nikolova et al. CELL CYCLE
- Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
- (2012) Tor-Christian Aase Johannessen et al. Expert Review of Anticancer Therapy
- Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines
- (2012) Dagmar Beier et al. JOURNAL OF NEURO-ONCOLOGY
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- DNA Damage Response and Growth Factor Signaling Pathways in Gliomagenesis and Therapeutic Resistance
- (2011) M. Squatrito et al. CANCER RESEARCH
- Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles
- (2011) Steve Quiros et al. CELL CYCLE
- Targeting DNA repair and the cell cycle in glioblastoma
- (2011) Brian M. Alexander et al. JOURNAL OF NEURO-ONCOLOGY
- Le traitement du gliome par les agents chimiothérapeutiques favorise la survie des cellules souches tumorales
- (2011) Anne-Marie Bleau et al. M S-MEDECINE SCIENCES
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells
- (2011) S. C. Short et al. NEURO-ONCOLOGY
- Prognostic implications of the DNA damage response pathway in glioblastoma
- (2011) Do-Hyun Nam ONCOLOGY REPORTS
- Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs
- (2011) Steve Quiros et al. PLoS One
- Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells
- (2011) Philip Schmalz et al. Cancers
- Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme
- (2011) Sabrina Facchino et al. Cancers
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis
- (2010) Roberto Pallini et al. CANCER
- Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide
- (2010) Yuichi Sato et al. CANCER BIOLOGY & THERAPY
- Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells
- (2010) Sarah E. Golding et al. CANCER BIOLOGY & THERAPY
- Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres
- (2010) Alicia M. Mihaliak et al. CANCER LETTERS
- -Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence
- (2010) C. A. Gilbert et al. CANCER RESEARCH
- Frontiers in targeting glioma stem cells
- (2010) Guido Frosina EUROPEAN JOURNAL OF CANCER
- The Bright and the Dark Sides of DNA Repair in Stem Cells
- (2010) Guido Frosina JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas
- (2010) J Bartkova et al. ONCOGENE
- Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
- (2010) Francesca Pistollato et al. STEM CELLS
- DNA ligase IV as a new molecular target for temozolomide
- (2009) Natsuko Kondo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs and p53
- (2009) S C Naumann et al. BRITISH JOURNAL OF CANCER
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
- (2009) B. Mukherjee et al. CANCER RESEARCH
- Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
- (2009) E. Bolderson et al. CLINICAL CANCER RESEARCH
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Rad51 Protein Expression and Survival in Patients with Glioblastoma Multiforme
- (2009) James W. Welsh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
- (2009) M. Ropolo et al. MOLECULAR CANCER RESEARCH
- DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
- (2009) G. Frosina MOLECULAR CANCER RESEARCH
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
- DNA double-strand breaks: Their production, recognition, and repair in eukaryotes
- (2009) Takeo Ohnishi et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
- (2009) M -A Westhoff et al. ONCOGENE
- A transcription co-factor integrates cell adhesion and motility with the p53 response
- (2009) A. S. Coutts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
- (2008) D. Beier et al. CANCER RESEARCH
- DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?
- (2008) Tor-Christian Aase Johannessen et al. CANCER TREATMENT REVIEWS
- Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
- (2008) J. N. Sarkaria et al. CLINICAL CANCER RESEARCH
- Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O6-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs
- (2008) Wynand P. Roos et al. DNA REPAIR
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma
- (2007) Jonathon F. Parkinson et al. JOURNAL OF CLINICAL NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now